Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Aon PLC (AON), CVS Caremark Corporation (CVS): LA-Based First Pacific Advisors’ Top Picks

Page 1 of 2

Editor’s Note: Related tickers: Aon PLC (NYSE:AON), Marsh & McLennan Companies, Inc. (NYSE:MMC), CVS Caremark Corporation (NYSE:CVS), Microsoft Corporation (NASDAQ:MSFT), Google Inc (NASDAQ:GOOG), Covidien plc (NYSE:COV), Thermo Fisher Scientific Inc. (NYSE:TMO)

Hedge funds are required to file 13F forms with the Securities and Exchange Commission after the end of each calendar quarter. One of the funds we track is First Pacific Advisors, managed by Robert Rodriguez and Steven Romick. We will review the five largest equity holdings of First Pacific, via its first quarter 13F. The original filing can be found here, and it’s important to note that piggybackers can have success if they know where to look; discover how to piggyback hedge funds here.

Let’s get started


Aon PLC (NYSE:AON) is the largest equity holding of First Pacific, according to the 13F. The fund disclosed ownership of 6,891,000 shares, down from 7,025,500 shares reported in the previous quarter. The value of the stake has, however, increased to $423.8 million from $390.6 million. Amongst insurance brokers, Aon PLC (NYSE:AON) has the second-largest market cap, which amounts to $20.26 billion, running second to the $22.0 billion market capitalization of Marsh & McLennan Companies, Inc. (NYSE:MMC). Aon PLC (NYSE:AON) has a forward P/E of 12.4x, good for fourth lowest in its industry.

The next largest holding listed in the 13F is CVS Caremark Corporation (NYSE:CVS), in which the fund has a $402.8 million stake. The fund’s stake is 7,325,600 shares, an increase of 103,100 shares from the end of December. The prior value of the stake was about $349.2 million. CVS Caremark Corporation (NYSE:CVS) is trading at a forward P/E of 13.2x and has a year-to-date return of slightly below 13%. More than 30 hedge funds from our database held shares of CVS Caremark Corporation (NYSE:CVS) at the end of last year.

The best of the rest

Next up is Microsoft Corporation (NASDAQ:MSFT). The 13F states that the fund owns 12,961,300 shares of the company, worth $370.8 million. In the previous round of 13F filings, the fund held a stake of 12,425,100 shares worth $332.1 million. Microsoft Corporation (NASDAQ:MSFT) is held by 95 of the hedge funds we track. Among companies from the technology sector, Microsoft has the second highest market cap, totaling $275.84 billion. Google Inc (NASDAQ:GOOG) holds the first position, with a market cap of $291.14 billion.

First Pacific has also disclosed owning 5,348,800 shares of Covidien plc (NYSE:COV), down from 5,399,500 shares held at the end of last year. The value of the equity stake advanced to $362.9 million, from $311.8 million. Covidien plc (NYSE:COV) shares sport a year-to-date return of above 15%. According to our database, over 30 hedge funds were invested in Covidien at the end of 2012. In the second quarter of its fiscal 2013, Covidien reported diluted GAAP EPS from continuing operations of $0.93, versus $1.01 a year earlier.

The fund also holds 3,865,800 shares of Thermo Fisher Scientific Inc. (NYSE:TMO), worth $295.7 million. In the prior quarter the fund reported 3,720,600 shares, worth $237.3 million. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has a forward P/E of 14.2x and a year-to-date return above 32.6%. In the previous round of 13F filings, 40 hedge funds from our database disclosed ownership in the company.

Final thoughts

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!